Skip to main content
Canadian Pharmacists Journal : CPJ logoLink to Canadian Pharmacists Journal : CPJ
. 2019 Jul 22;152(5):285–287. doi: 10.1177/1715163519866144

A call to action to implement prescribing authority to pharmacists for hypertension management

Nadia Khan, Alan Bell, Angelique Berg, Norm Campbell, Janusz Kaczorowski, Doreen Rabi, Ernesto L Schiffrin, Ross T Tsuyuki
PMCID: PMC6739652  PMID: 31534583

Background: Increased blood pressure is a leading risk for death and disability globally and in Canada.1 The World Health Organization HEARTS program outlines global best practices for cardiovascular disease prevention2 and uses hypertension as a key entry for managing noncommunicable disease and its risks in the health care system.

Enhancing primary care is one of the foundations to implementing the HEARTS and other interventions to prevent and control noncommunicable disease. One of the most important interventions in the HEARTS program is to use patient-centred team-based care. In Canada, pharmacists can play a critical role to enhance hypertension screening and management.

Recommendation: Pharmacist care, including prescribing, is recommended for adults with hypertension.

Purpose: This statement supports the advancement of a Pan-Canadian Framework for Healthy Blood Pressure and HEARTS that advocates for the utilization of human resources and expertise by expanding the role of pharmacists across Canada to aid in the prevention, diagnosis and management of hypertension.

On the basis that: Multidisciplinary collaboration in hypertension is a care delivery strategy that includes the patient, primary care providers (family physicians, pharmacists and/or nurse practitioners and/or other health professionals) working collaboratively to accomplish shared goals in the prevention, screening, diagnosis and management of hypertension.3,4

Current hypertension awareness and control rates in Canada are suboptimal, despite universal access to care and subsidization of medications.

Multiple factors, including lack of access and available consultation time for family physicians and lack of patient education, are driving factors in this suboptimal awareness and control.5,6 As a consequence, reductions on morbidity and mortality associated with blood pressure control remain unrealized in these patients.

Over 4.5 million Canadians are without a regular physician.7

In North America, patients visit pharmacists 5 to 7 times more frequently than physicians, positioning pharmacists and community pharmacies as additional touch points of health care contact.8

Pharmacists working collaboratively with physicians and/or nurses, conducting pharmacist-led patient education, feedback and suggested medication changes to physicians, and medication management, was associated with significant reductions in blood pressure, improved adherence to medications and a greater proportion of patients achieving target blood pressure compared with usual care.9-18

Pharmacist prescribing on top of usual physician care compared with usual physician care alone was associated with large reductions in blood pressure and a higher proportion of patients reaching target blood pressure.18

In all cases, pharmacist care should involve the patient and other care providers.

Several provinces are moving towards expanding the role of pharmacists and Alberta legislated independent prescribing legislation for pharmacists over 10 years ago.

System support, including structured treatment algorithms, communication and sharing of electronic health records between providers, health professional training in hypertension diagnosis and management, access to appropriate and accurate blood pressure and laboratory monitoring, delineation of team roles, registries with performance reporting and availability of self-management support tools for patients are critical elements for effective team-based care.19,20

Pharmacist prescribing and care is economically dominant (cost savings of $15.9 billion over a 30-year time horizon) compared to usual care.21

Collaborative care may help address the issue of physician burnout.

Call to Action

Federal, provincial and territorial governments to:

  • Support, develop and implement public and regulatory policies based on the best evidence to improve access to hypertension diagnosis and medication management by optimally utilizing health professional skills including pharmacist prescribing.

  • Monitor and evaluate the implementation and effects of utilization of pharmacists in collaborative practice environments.

  • Support the training and education of pharmacists on hypertension diagnosis and medication management as part of cardiovascular risk reduction education.

  • Support the sharing of electronic health records and diagnostic results between patients, physicians and pharmacists in collaborative practice environments.

  • Increase funding for research on optimal use and implementation of team-based care in supporting Canadians for improved coordination of care and effective chronic disease management.

Nongovernmental organizations to:

  • Act as advocates for improved access to team-based care, fully optimizing health professionals’ skills including pharmacist prescribing.

  • Promote and support the prioritization and integration of team-based care in health care delivery. ■

References

  • 1. Institute for Health Metrics and Evaluation. Global Burden of Disease Compare. Available: http://vizhub.healthdata.org/gbd-compare/ (accessed Jan. 15, 2019).
  • 2. World Health Organization. HEARTS: Technical package for cardiovascular disease management in primary health care. Available: https://www.who.int/cardiovascular_diseases/hearts/en/ (accessed July 8, 2019).
  • 3. Naylor MD, Coburn KD, Kurtzman ET, et al. Inter-professional team-based primary care for chronically ill adults: state of the science. Presented at the ABIM Foundation meeting to Advance Team-Based Care for the Chronically Ill in Ambulatory Settings. 2010. March 24-25; Philadelphia, PA. [Google Scholar]
  • 4. Mitchell P, Wynia R, Golden B, et al. Core principles and values of effective team-based health care. Discussion Paper. Washington (DC): Institute of Medicine; 2012. Available: https://nam.edu/wp-content/uploads/2015/06/VSRT-Team-Based-Care-Principles-Values.pdf (accessed July 8, 2019). [Google Scholar]
  • 5. Khatib R, Schwalm JD, Yusuf S, et al. Patient and healthcare provider barriers to hypertension awareness, treatment and follow up: a systematic review and meta-analysis of qualitative and quantitative studies. PLoS One 2014;9(1):e84238. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 6. Ogedegbe G. Barriers to optimal hypertension control. J Clin Hypertens (Greenwich) 2008;10(8):644-6. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 7. Statistics Canada. Access to a regular medical doctor, 2014. Available: www.statcan.gc.ca/pub/82-625-x/2015001/article/14177-eng.htm (accessed July 8, 2019).
  • 8. Campbell K. DCCT opens new opportunities for pharmacists. California Pharmacist 1993:26-27. [Google Scholar]
  • 9. Shaw RJ, McDuffie JR, Hendrix CC, et al. Effects of nurse-managed protocols in the outpatient management of adults with chronic conditions: a systematic review and meta-analysis. Ann Intern Med 2014;161(2):113-21. [DOI] [PubMed] [Google Scholar]
  • 10. Clark CE, Smith LF, Taylor RS, Campbell JL. Nurse led interventions to improve control of blood pressure in people with hypertension: systematic review and meta-analysis. BMJ 2010;341:c3995. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 11. Proia KK, Thota AB, Njie GJ, et al. Community Preventive Services Task Force. Team-based care and improved blood pressure control: a community guide systematic review. Am J Prev Med 2014;47(1):86-99.24933494 [Google Scholar]
  • 12. Santschi V, Chiolero A, Colosimo AL, et al. Improving blood pressure control through pharmacist interventions: a meta-analysis of randomized controlled trials. J Am Heart Assoc 2014;3(2):e000718. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 13. Pande S, Hiller JE, Nkansah N, Bero L. The effect of pharmacist-provided non-dispensing services on patient outcomes, health service utilisation and costs in low- and middle-income countries. Cochrane Database Syst Rev 2013;(2):CD010398. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 14. Sisson EM, Dixon DL, Kildow DC, et al. Effectiveness of a pharmacist-physician team-based collaboration to improve long-term blood pressure control at an inner-city safety-net clinic. Pharmacotherapy 2016;36(3):342-7. [DOI] [PubMed] [Google Scholar]
  • 15. Isetts BJ, Buffington DE, Carter BL, et al. Evaluation of pharmacists’ work in a physician-pharmacist collaborative model for the management of hypertension. Pharmacotherapy 2016;36(4):374-84. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 16. Carter BL, Rogers M, Daly J, et al. The potency of team-based care interventions for hypertension: a meta-analysis. Arch Intern Med 2009;169(19):1748-55. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 17. Carter BL, Coffey CS, Ardery G, et al. Cluster-randomized trial of a physician/pharmacist collaborative model to improve blood pressure control. Circ Cardiovasc Qual Outcomes 2015;8(3):235-43. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 18. Tsuyuki RT, Houle SK, Charrois TL, et al. Randomized trial of the effect of pharmacist prescribing on improving blood pressure in the community: The Alberta Clinical Trial in Optimizing Hypertension (RxACTION). Circulation 2015;132(2):93-100. [DOI] [PubMed] [Google Scholar]
  • 19. Löffler C, Koudmani C, Böhmer F, et al. Perceptions of interprofessional collaboration of general practitioners and community pharmacists — a qualitative study. BMC Health Serv Res 2017;17(1):224. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 20. Wells BG, Bertin RJ. A vision of pharmacy’s future roles, responsibilities, and manpower needs in the United States. Pharmacotherapy 2001;21(1):126-7. [PubMed] [Google Scholar]
  • 21. Marra C, Johnston J, Santschi V, Tsuyuki R. Cost-effectiveness of pharmacist care for managing hypertension in Canada. Can Pharm J (Ott) 2017. 150(3): 184–197. [DOI] [PMC free article] [PubMed] [Google Scholar]

Articles from Canadian Pharmacists Journal : CPJ are provided here courtesy of University of Toronto Press

RESOURCES